The stock has not done hugely well over the last five years but is poised for strong performance over the next decade.Many investors are biased toward stocks in their home country, especially the U.S. And who could fault them? The U.S. market has done phenomenally well over the last 40 to 50 years, producing huge winners for people who owned the likes of Microsoft and Apple, among many other stocks.But as we sit here today in late 2025, the U.S. stock market is trading at a premium average price-to-earnings ...

These stocks all have incredible short-term and long-term opportunities.We're getting into the last stretch of the year, a time when many investors take stock of their holdings and see if their portfolios need any changes. If your portfolio needs some extra growth, there are many amazing options -- and they're not all artificial intelligence (AI) stocks.In fact, if most of your growth is coming from AI stocks, you might want to reconsider your positions and make sure your portfolio is well diversified. Alth ...

文章核心观点 - 文章推荐两只具有长期增长潜力的股票，认为它们值得关注 [1][2] MercadoLibre (MELI) - 公司是拉丁美洲十多个国家电子商务和数字金融服务的明确领导者 [3] - 已建立的品牌和广泛的运营规模是难以复制的显著竞争优势 [3] - 拉丁美洲的电子商务渗透率落后于美国等发达市场数年，为公司保留了显著且持久的增长空间 [4] - 该地区大量没有银行账户的人口为公司金融科技服务提供了巨大且不断增长的市场机会 [5] - 公司的各项服务（Mercado Pago、Mercado Envíos、Mercado Crédito）相互促进，创造飞轮效应 [5][6] - 管理层持续投资基础设施（如物流中心和技术升级）以保持竞争优势并推动长期扩张 [8] - 第三季度净收入达到74亿美元，同比增长40%，连续第27个季度实现超过30%的同比增长 [9] - 第三季度运营收入达到7.24亿美元，同比增长30%，调整后自由现金流为2.06亿美元 [9] - 第三季度总商品交易额（GMV）达到165亿美元，同比增长28%，总支付额（TPV）达到712亿美元，同比增长41% [9] - 当前股价为2069.54美元，当日上涨1.78% [7] Eli Lilly (LLY) - 公司因其GLP-1疗法的巨大成功近年来获得更多投资者关注，但同时也是全球最古老的制药公司之一，在神经科学、肿瘤学和免疫学等领域拥有多元化产品组合 [11] - 公司成立于1876年，拥有悠久的创新历史，例如在20世纪40年代大规模生产青霉素 [12] - 公司的替尔泊肽（Tirzepatide，商品名Mounjaro用于2型糖尿病，Zepbound用于减肥）在2025年第三季度成为全球最畅销药物 [12] - 第三季度收入同比飙升54% [13] - 公司在一个预计到2030年价值将超过1000亿美元的减肥市场中占据领先市场份额，并成为第一家市值超过1万亿美元的医疗保健公司 [13] - 当前股价为1075.47美元，当日下跌2.61%，市值约为10170亿美元 [14][15] - 除当前畅销药外，公司在新药研发管线方面前景广阔，涵盖新型放射性药物、靶向小分子和抗体疗法 [15] - 关键管线药物orforglipron是一种口服GLP-1疗法，比注射剂更方便，预计明年获批上市，其小分子结构可能使其比肽类疗法更便宜、更容易生产和分销 [15][17] - 公司正进行大规模制造投资以满足需求，并利用人工智能加速药物开发，在英伟达帮助下构建行业最强大的超级计算机之一 [18]

This Latin American e-commerce stock looks poised for more gains.MercadoLibre (MELI +1.78%) doesn't get as much attention as some of its U.S.-based e-commerce counterparts, but the Latin American e-commerce operator has been a big winner for investors over the years.Since its 2007 initial public offering (IPO), the stock is up 7,000%, and it's been a winner over virtually any time frame during its history, as you can see from the chart below: Recently, however, MercadoLibre has pulled back due to concerns a ...

These stocks can power your returns for years to come.Holding shares of growing companies is one of the most efficient ways to build wealth over time. The key is to maintain a long-term mindset, ignore short-term volatility in the stock market, and concentrate on investing in companies that possess a competitive edge.Here are two growth stocks that would make solid investments right now. 1. RedditReddit (RDDT +4.26%) has quickly become one of the top three most visited sites in the U.S., turning the convers ...

This impacts not only growth but also pressures our EBIT margin. Despite the headwind Argentina continues to be a very profitable market with strong long-term growth perspective. Operating income of USD 724 million, grew by 30% year-on-year. This demonstrates our ability to balance growth investments and profitability and the power of scale, which should continue to play in our favor. Our strategic investments in free shipping, logistics, 1P and credit card continued to deliver strong top line growth while ...

MercadoLibre, Inc. (NASDAQ:MELI) is one of the best large cap stocks to invest in for the long term. Citi slashed the price target on MercadoLibre, Inc. (NASDAQ:MELI) to $2,500 from $2,700 on November 17, keeping a Buy rating on the stock. The firm also opened a “90-day negative short-term” on the company, backing the outlook with investor concerns regarding a potential downward earnings estimate revisions and competition. Is MercadoLibre, Inc. (MELI) Among The Aggressive Stocks Picked by Hedge Funds? Ho ...

The answer depends on how long one has been an investor.Latin America's MercadoLibre (MELI +2.29%) -- an e-commerce, logistics, and financial technology (fintech) business -- has been quite good for investors over this past decade. In fact, it's the 35th best stock over the last 10 years (among stocks that are valued at $5 billion or more), according to MacroTrends, achieving 32% annualized returns.It's not just over the past decade. Indeed, MercadoLibre stock is up over 100% in just the last three years, w ...

Mercado Libre is reportedly investing more than ever before in coupons for this week’s Black Friday sale amid heightened competition in Latin America from other online retailers such as Amazon, Shein, Shopee and Temu.By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions .Complete the form to unlock this article and enjoy unlimited free access to ...

公司概况 - 公司是拉丁美洲领先的电子商务和金融科技企业，常被比作亚马逊，总部位于乌拉圭，业务遍及18个国家 [1] - 公司建立了强大的物流网络，并推出了名为Meli+的会员计划以提升客户体验 [1] 财务表现与增长 - 第三季度收入同比增长39%，增长动力来自商业、金融科技和信贷板块 [3] - 强劲的财务表现得益于创纪录的买家活动和战略性投资 [3] 业务运营亮点 - 物流网络中的当日或次日达配送量同比增长28% [4] - 金融科技部门MercadoPago持续快速扩张，对公司财务表现做出贡献 [4] 市场表现与分析师观点 - UBS分析师Kaio Prato设定的新目标价为2,900美元，较此前目标3,000美元有所下调，但基于1,951.78美元的交易价，潜在上涨空间为48.58% [2] - 公司股价近期上涨2.74%，即52.03美元 [2] - 华尔街分析师普遍乐观，平均经纪商建议为1.58，介于强力买入和买入之间，20家经纪商中有75%给予强力买入评级 [5]